Bespak and H&T Presspart Ink Pact To Advance transition To low GWP Propellants

Bespak, a main contract development and manufacturing organization (CDMO) focused on orally breathed-in and nasal drug-device gadget blend items, and H&T Presspart, a pharmaceutical firm, declared a coordinated effort to speed up the business...

Zydus biopharma Arm Buys Global Proprietary Rights For Progeria Treatment

Sentynl Therapeutics Inc (Sentynl), a US-based biopharmaceutical organization entirely claimed by Ahmedabad-settled Zydus Lifesciences, as of late finished the procurement of worldwide exclusive rights for Zokinvy. Zokinvy is the first and only...

Context Therapeutics Bags US FDA Nod of IND Application

Context Therapeutics Inc, a biopharmaceutical firm creating therapies for solid tumors based in Philadelphia, reported that the US FDA has approved its Investigational New Drug application for CTIM-76, a bispecific antibody that targets Claudin 6...

Cocrystal Pharma Concludes Enrolment in Phase 2a Study of CC-42344

Cocrystal Pharma, Inc. reports that the randomized, double-blind, placebo-controlled phase 2a human challenge clinical study assessing the safety, tolerability, antiviral, and clinical measurements of its novel, oral PB2 inhibitor CC-42344, which...

Abbott Launches Next Generation XIENCE Sierra Stent in India

Abbott, the global healthcare company,announced the launch of XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. XIENCE Sierra is one of the latest generation stents in the XIENCE™ family, now available to people suffering...

4th Annual Pharma GMP & Quality Management 2024

The 4th Annual Pharma GMP & Quality Management 2024, held at NOVOTEL Mumbai International Airport on April 25th and 26th, emerged as a pivotal event in the pharmaceutical industry landscape, fostering collaboration, innovation, and excellence.

© 2024 India Pharma Outlook. All Rights Reserved.